Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1Phase 1/2 1Phase 1 1

Status

Active not recruiting 3Unknown 1Terminated 1Completed 1

Sponsor Class

OTHER 5NIH 1

Study Type

Interventional 4Observational 2

Sponsor

Cancer Type

CNS 6Sarcoma 1Endocrine 1

Conditions

Brain Neoplasms 129Neoplasm Metastasis 33Glioblastoma 24Melanoma 22Lung Neoplasms 16Carcinoma, Non-Small-Cell Lung 16Breast Neoplasms 15Glioma 12Small Cell Lung Carcinoma 8Neoplasms 8Gliosarcoma 8Central Nervous System Neoplasms 7Neuroma, Acoustic 6Meningioma 6Carcinoma, Renal Cell 6Astrocytoma 5Spinal Cord Neoplasms 4Recurrence 4Sarcoma 3Oligodendroglioma 3Gastrointestinal Neoplasms 3Breast Neoplasms, Male 3Uveal Melanoma 2Radiation Injuries 2Prostatic Neoplasms 2Kidney Neoplasms 2Fatigue 2Depression 2Colorectal Neoplasms 2Anxiety Disorders 2

Interventions

Magnetic Resonance Spectroscopy 16Hydroxyurea 7Everolimus 7Bevacizumab 7lutetium Lu 177 dotatate 6gallium Ga 68 dotatate 6Radiosurgery 6Proton Therapy 6Specimen Handling 5pembrolizumab 4Surveys and Questionnaires 4Surgical Procedures, Operative 4Radiotherapy 4Imatinib Mesylate 4Cyclophosphamide 42-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 4aldesleukin 3abemaciclib 3Tranexamic Acid 3Temozolomide 3Sunitinib 3Sodium Chloride 3Radiotherapy, Intensity-Modulated 3Observation 3Nivolumab 3Ga(III)-DOTATOC 390Y-octreotide, DOTA-Tyr(3)- 3vistusertib 2trametinib 2ribociclib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Meningioma × Radiosurgery × CNS × Clear all
NCT03604978 2026-05-13

Nivolumab and Multi-fraction Stereotactic Radiosurgery With or Without Ipilimumab in Treating Patients With Recurrent Grade II-III Meningioma

National Cancer Institute (NCI)

Phase 1/2 Active not recruiting
38 enrolled
CNS

Meningioma

NCT06466720 2026-05-04

CoDeB-Rad

University of Nottingham

Active not recruiting
80 enrolled
CNS

Brain Neoplasms, Meningioma, Cognitive Dysfunction

NCT04659811 2026-04-15

Stereotactic Radiosurgery and Immunotherapy (Pembrolizumab) for the Treatment of Recurrent Meningioma

University of California, San Francisco

Phase 2 Active not recruiting
35 enrolled
CNS

Meningioma

NCT01324635 2025-05-02

Panobinostat and Stereotactic Radiation Therapy in Treating Patients With Brain Tumors

Thomas Jefferson University

Phase 1 Terminated
17 enrolled
CNS

Brain Neoplasms, Glioma, Meningioma

NCT02974127 2021-02-21

MuRaLM

Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta

Unknown
178 enrolled
CNS

Meningioma

NCT01347307 2020-06-18

Stereotactic Body Radiotherapy for Spine Tumors

Mercy Research

Phase NA Completed
38 enrolled 11 charts
CNSEndocrineSarcoma

Arteriovenous Malformations, Chordoma, Meningioma, Neurilemmoma, Neurofibroma, Paraganglioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡